Nautilus Biotechnology Analyst Ratings
Nautilus Biotechnology Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 94.81% | Morgan Stanley | $6 → $6 | Reiterates | Equal-Weight → Equal-Weight |
| 08/03/2022 | 94.81% | Morgan Stanley | $8 → $6 | Maintains | Equal-Weight |
| 08/03/2022 | -35.06% | Goldman Sachs | $4 → $2 | Maintains | Neutral |
| 07/14/2022 | 29.87% | Goldman Sachs | $5 → $4 | Maintains | Neutral |
| 04/13/2022 | 62.34% | Goldman Sachs | $9 → $5 | Maintains | Neutral |
| 01/06/2022 | 159.74% | Morgan Stanley | → $8 | Initiates Coverage On | → Equal-Weight |
| 11/02/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 08/04/2021 | 224.68% | Goldman Sachs | → $10 | Initiates Coverage On | → Neutral |
| 07/13/2021 | 322.08% | Jefferies | → $13 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/03/2023 | 94.81% | 摩根士丹利 | 6 美元 → 6 美元 | 重申 | 等重 → 等重 |
| 08/03/2022 | 94.81% | 摩根士丹利 | 8 美元 → 6 美元 | 维护 | 重量相等 |
| 08/03/2022 | -35.06% | 高盛 | 4 美元 → 2 美元 | 维护 | 中立 |
| 07/14/2022 | 29.87% | 高盛 | 5 美元 → 4 美元 | 维护 | 中立 |
| 2022 年 4 月 13 日 | 62.34% | 高盛 | 9 美元 → 5 美元 | 维护 | 中立 |
| 01/06/2022 | 159.74% | 摩根士丹利 | → 8 美元 | 启动覆盖开启 | → 重量相等 |
| 11/02/2021 | — | Cowen & Co. | 启动覆盖开启 | → 跑赢大盘 | |
| 08/04/2021 | 224.68% | 高盛 | → 10 美元 | 启动覆盖开启 | → 中立 |
| 2021 年 7 月 13 日 | 322.08% | 杰富瑞 | → 13 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Nautilus Biotechnology (NAUT)?
鹦鹉螺生物技术（NAUT）的目标价格是多少？
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on August 3, 2023. The analyst firm set a price target for $6.00 expecting NAUT to rise to within 12 months (a possible 94.81% upside). 1 analyst firms have reported ratings in the last year.
摩根士丹利于2023年8月3日公布了鹦鹉螺生物技术（纳斯达克股票代码：NAUT）的最新目标股价。这家分析公司将目标股价定为6.00美元，预计NAUT将在12个月内升至12个月内（可能上涨94.81％）。去年有1家分析公司公布了评级。
What is the most recent analyst rating for Nautilus Biotechnology (NAUT)?
分析师对鹦鹉螺生物技术（NAUT）的最新评级是多少？
The latest analyst rating for Nautilus Biotechnology (NASDAQ: NAUT) was provided by Morgan Stanley, and Nautilus Biotechnology reiterated their equal-weight rating.
Nautilus Biotelus Biotechnology（纳斯达克股票代码：NAUT）的最新分析师评级由摩根士丹利提供，鹦鹉螺生物技术重申了其同等权重评级。
When is the next analyst rating going to be posted or updated for Nautilus Biotechnology (NAUT)?
Nautilus Biotelus Biotechnology（NAUT）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nautilus Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nautilus Biotechnology was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析师在进行了广泛的研究（包括浏览公开财务报表、与Nautilus Biotelus Biotechnology的高管和客户交谈，以及听取财报电话会议）后得出了股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Nautilus Biotelus Biotechnology的最后一次评级是在2023年8月3日提交的，因此您应该预计下一个评级将在2024年8月3日左右公布。
Is the Analyst Rating Nautilus Biotechnology (NAUT) correct?
分析师对鹦鹉螺生物技术（NAUT）的评级是否正确？
While ratings are subjective and will change, the latest Nautilus Biotechnology (NAUT) rating was a reiterated with a price target of $6.00 to $6.00. The current price Nautilus Biotechnology (NAUT) is trading at is $3.08, which is out of the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的Nautilus Biotechnology（NAUT）的评级得到了重申，目标股价为6.00美元至6.00美元。Nautilus Biotelus Biotechnology（NAUT）目前的交易价格为3.08美元，超出了分析师的预测区间。